MDT and patient perspectives on antihyperglycemic therapies and their association with weight loss

touchMDT for touchENDOCRINOLOGY

Listen to key experts from a multidisciplinary team and a patient explore the importance of weight loss in T2D; GLP-1 RAs and SGLT2is and their association with weight loss; plus the patient’s experience of using a GLP-1 RA to manage their T2D and obesity. 

The multidisciplinary team and patient

• Endocrinologist: Professor Dr med Michael Nauck, Germany
• Primary care specialist: Professor Stewart Harris, Canada
• Patient: Tammie Snowden, USA

This touchPODCAST is for HCPs only.

This activity is funded by an unrestricted independent medical education grant from Eli Lilly. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchendocrinologyime.org/antihyperglycemic-therapy-in-T2D-obesity-MDT-outlook//